US 9137973
Pyrazolopyridine kinase inhibitors
granted A61PA61P1/00A61P1/04
Quick answer
US patent 9137973 (Pyrazolopyridine kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P11/06, A61P17/06